(EMAILWIRE.COM, April 29, 2008 ) Denver, CO - LegalView recently updated its Heparin information portal to include the latest information on the Baxter Heparin recall (http://baxter-heparin.legalview.com) that may have caused severe allergic reactions and the deaths of more than 80 patients. Investigating the source of contamination has led U.S. officials to a manufacturing plant in China, where over-sulfated chrondroitin sulfate was reportedly chemically altered to simulate Heparin. The use of the compound would have allowed for a less expensive production of the original Heparin, however, the U.S. Food and Drug Administration (FDA) never approved the compound for use in Heparin. Individuals who may have been victim of the tainted Heparin batch should contact a pharmaceutical attorney for details on the development of a potential Heparin lawsuit (http://baxter-heparin.legalview.com).

Heparin is an anticoagulant that is often used during surgical procedures such as kidney dialysis or heart surgery. It thins the blood in order to avoid the development of deep vein thrombosis, which can be deadly in surgery. Heparin is derived from pig intestines and has been imported, predominately from China, since the 1930s.

Manufacturers of the drug, Baxter International Inc., issued the Heparin recall (http://baxter-heparin.legalview.com) in January but have since been battling with Chinese regulators who claim the Baxter Heparin contamination occurred at the Baxter New Jersey factory. Chinese officials have said that the Heparin was manufactured and sent to several other countries who had not reported the side effects that the Baxter Heparin (http://baxter-heparin.legalview.com) victims did. However, the FDA claims, upon the results of their investigation, that the tainted Heparin went to 12 countries. The FDA also explained that the side effects did occur in individuals in Germany, but were more prevalent in the United States because of the practice among U.S. surgeons to use more Heparin in patients.

For more information on this or other pharmaceutical complications, visit http://www.LegalView.com, where individuals can find information on a range of issues such as details of a potential Zetia lawsuit (http://zetia.legalview.com), mesothelioma litigation or construction accidents.

Zetia is a prescription medication that can be used to treat dyslipidemia, occurring when the amount of lipids in the bloodstream becomes imbalanced, thus increasing the amount of bad cholesterol among an individual. A study that was released evaluating the drug found that the drug was actually less beneficial than generic versions, despite being more than three times as expensive. To learn about a Zetia lawsuit contact a pharmaceutical law firm in your area.

Individuals needing help locating mesothelioma lawyers (http://mesothelioma.legalview.com) or a construction accident attorney (http://construction.legalview.com) can use the mesothelioma practice area at http://mesothelioma.legalview.com and for construction accidents, visit http://construction.legalview.com/.

About LegalView:

LegalView.com is a public service brought to you by Legal WebTV Network, LLC, a Limited Liability Corporation created by a group of the nation's most highly respected law firms: Anapol Schwartz; Brent Coon and Associates; Burg Simpson; Cohen, Placitella and Roth; James F. Humphreys and Associates; Lopez McHugh; and Thornton and Naumes. For more information on the accomplishments and track records of LegalView.com's superior sponsoring law firms and to get in touch with LegalView attorneys, visit LegalView at www.LegalView.com/.

Contact Information:
LegalView
Katie Kelley
Tel: 720-771-3246
Email us


This is a press release. Press release distribution and press release services by EmailWire.Com: http://www.emailwire.com/us-press-release-distribution.php.